| Turchia | Austria | Spagna | |
| Radioterapia per il carcinoma esofageo | da $7,000 | da $20,000 | da $15,000 |
| Radioterapia per il cancro colorettale | da $7,000 | da $12,000 | da $10,000 |
| Esofagectomia | da $18,000 | da $30,000 | da $30,000 |
| Chemioterapia per carcinoma mammario | da $1,200 | da $15,000 | da $3,500 |
| Chemioterapia per carcinoma esofageo | da $5,000 | da $12,000 | da $3,500 |
Il Prof. Christoph Zielinski è un leader riconosciuto a livello globale nell'oncologia medica, con oltre 40 anni di esperienza e un lavoro pionieristico nell'immunoterapia del cancro.
Univ.-Prof. Dr. Wolfgang Johannes Köstler is a board-certified specialist for Internal Medicine, Hematology/Oncology, and Intensive Care Medicine who specializes in hematology & internal oncology, intensive care medicine. He is one of the top-rated breast cancer and sarcoma oncologist specialists and has extensive experience in the field and has received degrees from the Medical University of Vienna and the Weizmann Institute of Science. He has also had special training at Memorial Sloan-Kettering Cancer Center and Royal Prince Alfred Hospital.
Dr. Sebastian F. Schoppmann is an expert in general and visceral surgery. He has focused on upper gastrointestinal (GI) surgery since 2007. He leads the Gastroesophageal Tumor Unit (CCC-GET) at the Comprehensive Cancer Center Vienna. He is also an Associate Professor of Surgery at the Medical University of Vienna.
Dr. Schoppmann has published over 240 peer-reviewed articles. He serves as a consulting or associate editor for several leading surgical and oncology journals. He is the General Secretary of the Austrian Society of Surgical Oncology. He has also held important leadership roles in surgical oncology organizations. His work has helped advance upper-GI cancer surgery.
Dr. Arnulf Ferlitsch is a specialist in internal medicine, gastroenterology, and hepatology. He completed his medical studies in Vienna in 1998. He continued his training at top institutions, including UCLA and the University of Pennsylvania. From 2000 to 2010, he focused on internal medicine, gastroenterology, hepatology, and intensive care.
Dr. Ferlitsch has received several research awards, such as the UEGW Best Abstract Award (2003, 2005, 2008, 2009, 2010, 2012), the Ferring Prize, and the Skoda Prize. He founded the hepatic hemodynamics laboratory and the liver cirrhosis outpatient clinic at the Medical University of Vienna. Since 2018, he has led the Department of Internal Medicine I at the Hospital of the Barmherzigen Brüder in Vienna.